Ferring courts sporting seniors for Euflexxa

Share this article:
Sports sponsorships and awareness campaigns aimed at seniors are staples of pharmaceutical communications. Ferring Pharmaceuticals has found a way to combine them with a multi-year sponsorship of the National Senior Games Association on behalf of its osteoarthritis treatment Euflexxa.

The Suffern, NY-based company will serve as an exclusive sponsor of the Summer National Senior Games—The Senior Olympics Presented by Humana, to be held from June 22-July 7 in Louisville, KY. Representing the brand at the games will be 1976 Olympic gold medalist and OA sufferer Bruce Jenner.

Ferring's William Garbarini, executive director for sales and marketing, said in a statement: “Our goal is to educate people about knee osteoarthritis and the available treatment options while supporting those who live with it every day. What better way to promote active aging than to be a part of an event as important as the Senior Games?”

The Games are billed as “the largest multi-sport event in the world for seniors 50 and over.” This year's event is expected to draw more than 12,000 athletes and 45,000 attendees over its 16 days.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...